<DOC>
	<DOCNO>NCT01609894</DOCNO>
	<brief_summary>The propose research investigate individualize fortification breast milk base daily milk analysis carbohydrate , protein , fat content randomize double blind control trial . The combination additional fat , carbohydrate protein commercial fortifier added ensure milk contains target amount nutrient . Growth development infant compare infant feed mother 's milk supplement current standard amount . The postnatal growth infant assess measure weight , length head circumference fat lean mass use highly accurate , non-invasive method throughout intervention period first follow-up visit discharge 3 month . Neurological development analyze age 18 month . The investigator hypothesize individualized fortification breast milk improve nutritional intake preterm infant , optimize growth , thus positively impact neurodevelopment health .</brief_summary>
	<brief_title>Individualized Fortification Breast Milk</brief_title>
	<detailed_description />
	<mesh_term>Growth Disorders</mesh_term>
	<criteria>Inclusion criterion : 1 . Gestational age &lt; 32weeks ( maternal date early fetal ultrasound ) ; 2 . Tolerating enteral intake ≥ 100 ml/kg/d ≥ 24h ; 3 . Subject anticipated receive intervention ≥ 3 consecutive week full enteral feeding ( ≥ 150 mL/kg/d ) achieve ; 4 . Written inform consent obtain infant 's legal representative . Exclusion criterion : 1 . Infants intrauterine growth restriction , small gestational age define weight less 3rd percentile use sex specific reference data birth weight 2 . Gastrointestinal malformation , major congenital anomaly chromosomal abnormality ; 3 . Babies enterostoma short gut syndrome ; 4 . Necrotizing enterocolitis , define feed intolerance associate positive xray finding ( pneumatosis intestinalis Bell Stage 2 ; air biliary tract free air peritoneum Bell Stage 3 ) ; 5 . Renal disease , define symptom ( oliguria , anuria , proteinuria , hematuria ) associate increase blood urea nitrogen 10 mmol/L79 creatinine 130 mmol/L80 ; 6 . Hepatic dysfunction , define jaundice ( direct bilirubin &gt; 1.0 mg/dl ) associate one abnormal liver function test ( AST , ALT GGT ) ; 7 . Participation another clinical trial may affect outcome study ; 8 . Probability transfer another NICU level II nursery outside McMaster Children 's Hospital minimum period three week complete . Postrandomisation exclusion criterion : 1 . Infants feed 25 % mean caloric intake consecutive week formula milk ; 2 . Fluid restriction &lt; 140mL/kg/d ≥ 3 consecutive day ; 3 . Sepsis infant gramnegative sepsis remove study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>32 Weeks</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Postnatal development</keyword>
	<keyword>Breast milk fortification</keyword>
	<keyword>Composition breast milk</keyword>
</DOC>